Helius Therapeutics plans to merge with others into a health group comprising manufacturing, prescribing and dispensing of medicinal cannabis products with the aim of boosting patient numbers significantly within a few years.
The merger, yet to be ratified by the company's shareholders, will see
Want to read more? It's easy.
Choose your best value subscription option
Student
Exclusive FREE offer for uni students studying at a New Zealand university (valued at $499).
